WO2002038174A3 - Vaccins contenant des proteines hantavirus recombinantes, leur procede de production et leur utilisation - Google Patents

Vaccins contenant des proteines hantavirus recombinantes, leur procede de production et leur utilisation Download PDF

Info

Publication number
WO2002038174A3
WO2002038174A3 PCT/DE2001/004213 DE0104213W WO0238174A3 WO 2002038174 A3 WO2002038174 A3 WO 2002038174A3 DE 0104213 W DE0104213 W DE 0104213W WO 0238174 A3 WO0238174 A3 WO 0238174A3
Authority
WO
WIPO (PCT)
Prior art keywords
vaccines
proteins
producing
methods
containing recombinant
Prior art date
Application number
PCT/DE2001/004213
Other languages
German (de)
English (en)
Other versions
WO2002038174A2 (fr
Inventor
Rainer Ulrich
Ausra Dargeviciute
Kestutis Sasnauskas
Aake Lundkvist
Original Assignee
Humboldt Uni Zu Berlin Univers
Inst Of Biotechnology
Rainer Ulrich
Ausra Dargeviciute
Kestutis Sasnauskas
Aake Lundkvist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humboldt Uni Zu Berlin Univers, Inst Of Biotechnology, Rainer Ulrich, Ausra Dargeviciute, Kestutis Sasnauskas, Aake Lundkvist filed Critical Humboldt Uni Zu Berlin Univers
Priority to AU2002221553A priority Critical patent/AU2002221553A1/en
Publication of WO2002038174A2 publication Critical patent/WO2002038174A2/fr
Publication of WO2002038174A3 publication Critical patent/WO2002038174A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des vaccins contre les hanta virus, leur procédé de production et leur utilisation. Ces vaccins ont comme domaine d'application la médecine et la médecine vétérinaire. L'invention concerne également l'utilisation d'un système de forte expression de levure qui permet d'obtenir de grandes quantités de protéines hantavirus recombinantes. Les protéines recombinantes sont nettoyées par centrifugation en gradient de densité ou par chromatographie d'affinité. L'obtention des protéines à partir de cellules de levure garantit qu'elles soient exemptes d'endotoxine et qu'elle conviennent à des applications humaines comme vaccins et dans le développement de diagnostics.
PCT/DE2001/004213 2000-11-08 2001-11-07 Vaccins contenant des proteines hantavirus recombinantes, leur procede de production et leur utilisation WO2002038174A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002221553A AU2002221553A1 (en) 2000-11-08 2001-11-07 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10055886A DE10055886A1 (de) 2000-11-08 2000-11-08 Impfstoffe, die rekombinante Hantavirusproteine enthalten, Verfahren zu iher Herstellung und ihre Verwendung
DE10055886.0 2000-11-08

Publications (2)

Publication Number Publication Date
WO2002038174A2 WO2002038174A2 (fr) 2002-05-16
WO2002038174A3 true WO2002038174A3 (fr) 2003-08-28

Family

ID=7662912

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2001/004213 WO2002038174A2 (fr) 2000-11-08 2001-11-07 Vaccins contenant des proteines hantavirus recombinantes, leur procede de production et leur utilisation

Country Status (3)

Country Link
AU (1) AU2002221553A1 (fr)
DE (1) DE10055886A1 (fr)
WO (1) WO2002038174A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8333918B2 (en) 2003-10-27 2012-12-18 Kimberly-Clark Worldwide, Inc. Method for the production of nonwoven web materials
CN101249261B (zh) * 2008-03-18 2010-10-27 中国疾病预防控制中心病毒病预防控制所 一种肾综合征出血热粘膜免疫疫苗及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000648A1 (fr) * 1993-06-24 1995-01-05 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Acides nucleiques d'un nouvel hantavirus et reactifs associes de detection et prevention d'infections
WO1999001153A1 (fr) * 1997-07-03 1999-01-14 The University Of New Mexico Hantavirus du rio mamore
DE19750220A1 (de) * 1997-11-13 1999-05-20 Max Delbrueck Centrum Verfahren zur Gewinnung von virusähnlichen Partikeln auf der Basis von Polyomaviren
WO2000044406A2 (fr) * 1999-01-29 2000-08-03 U.S. Medical Research Institute Of Infectious Diseases Vaccins adn diriges contre les infections a hantavirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916754A (en) * 1995-02-17 1999-06-29 The United States Of America As Represented By The Department Of Health And Human Services Bayou hantavirus and related methods
US5879968A (en) * 1996-11-18 1999-03-09 International Rectifier Corporation Process for manufacture of a P-channel MOS gated device with base implant through the contact window

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000648A1 (fr) * 1993-06-24 1995-01-05 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Acides nucleiques d'un nouvel hantavirus et reactifs associes de detection et prevention d'infections
WO1999001153A1 (fr) * 1997-07-03 1999-01-14 The University Of New Mexico Hantavirus du rio mamore
DE19750220A1 (de) * 1997-11-13 1999-05-20 Max Delbrueck Centrum Verfahren zur Gewinnung von virusähnlichen Partikeln auf der Basis von Polyomaviren
WO2000044406A2 (fr) * 1999-01-29 2000-08-03 U.S. Medical Research Institute Of Infectious Diseases Vaccins adn diriges contre les infections a hantavirus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DARGEVICIUTE A ET AL: "Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 20, no. 29-30, 4 October 2002 (2002-10-04), pages 3523 - 3531, XP004381816, ISSN: 0264-410X *

Also Published As

Publication number Publication date
DE10055886A1 (de) 2002-05-29
WO2002038174A2 (fr) 2002-05-16
AU2002221553A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
Weissman et al. HPLC purification of in vitro transcribed long RNA
WO2007067730A3 (fr) Anticorps monoclonaux humains contre la proteine tyrosine kinase 7 (ptk7) et procedes pour utiliser des anticorps anti-ptk7
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
AU2926401A (en) Novel chimeric proteins and methods for using the same
BRPI0517457A (pt) métodos para reenovelamento de anticorpos recombinantes
DE60336228D1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
ATE279947T1 (de) Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
WO2007038637A3 (fr) Anticorps monoclonaux humains diriges contre cd70
WO1998008542A3 (fr) Composes et procedes destines au traitement et au diagnostic d'infections mycobacteriennes
WO2001098334A3 (fr) Antigenes de streptocoque
ATE479756T1 (de) Streptococcus pneumoniae-antigene und impfstoffe
WO2008060367A3 (fr) Anticorps humains qui se lient au cxcr4, et leurs utilisations
WO2003029403A3 (fr) Proteines ciblant les cellules d'expression des recepteurs de mannose via l'expression dans des cellules d'insectes
CY1112110T1 (el) Κυκλικο μοριο dna το οποιο διαθετει μια συμβατικη αφετηρια αντιγραφης, η διαδικασια παρασκευης του και η χρηση του στην γονιδιακη θεραπεια
PT1062325E (pt) Purificacao de preparacoes de virus
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
WO2002038174A3 (fr) Vaccins contenant des proteines hantavirus recombinantes, leur procede de production et leur utilisation
WO1998023750A3 (fr) Chemokines de mammiferes
ATE313559T1 (de) Fusionsprotein aus hpv-l1 und einem peptid, das ein vlp bilden kann und als vehikel zum einschleusen eines peptids in eine zelle dienen kann, sowie dessen medizinische verwendungen
DK1287142T3 (da) Nukleinsyremolekyle omfattende en for et SDF-1 gamma chemokin, en neuropeptid-præcursor eller mindst et neuropeptid kodende nukleinsyresekvens
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DE59611307D1 (de) Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln
AU2002317474A1 (en) Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WD Withdrawal of designations after international publication

Free format text: DE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP